Literature DB >> 9417830

Characteristics of human fetal spinal cord grafts in the adult rat spinal cord: influences of lesion and grafting conditions.

M A Giovanini1, P J Reier, T A Eskin, E Wirth, D K Anderson.   

Abstract

The present study evaluated the growth potential and differentiation of human fetal spinal cord (FSC) tissue in the injured adult rat spinal cord under different lesion and grafting conditions. Donor tissue at 6-9 weeks of gestational age was obtained through elective abortions and transplanted either immediately into acute resection (solid grafts) or into chronic contusion (suspension and solid grafts) lesions (i.e., 14-40 days after injury) in the thoracic spinal cord. The xenografts were then examined either histologically in plastic sections or immunocytochemically 1-3 months postgrafting. Intraspinal grafts in acute lesions demonstrated an 83% survival rate and developed as well-circumscribed nodules that were predominantly composed of immature astrocytes. Solid-piece grafts in chronic contusion lesions exhibited a 92% survival rate and also developed as nodular masses. These grafts, however, contained many immature neurons 2 months postgrafting. Suspension grafts in chronic contusion lesions had an 85% survival rate and expanded in a nonrestrictive, diffuse pattern. These transplants demonstrated large neuronally rich areas of neural parenchyma. Extensive neuritic outgrowth could also be seen extending from these grafts into the surrounding host spinal cord. These findings show that human FSC tissue reliably survives and differentiates in both acute and chronic lesions. However, both the lesion environment and the grafting techniques can greatly influence the pattern of differentiation and degree of host-graft integration achieved. Copyright 1997 Academic Press.

Entities:  

Mesh:

Year:  1997        PMID: 9417830     DOI: 10.1006/exnr.1997.6703

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  15 in total

Review 1.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

2.  Differential activation of astrocytes and microglia after spinal cord injury in the fetal rat.

Authors:  Yoshinori Fujimoto; Takeshi Yamasaki; Nobuhiro Tanaka; Yu Mochizuki; Hiroki Kajihara; Yoshikazu Ikuta; Mitsuo Ochi
Journal:  Eur Spine J       Date:  2005-11-16       Impact factor: 3.134

3.  Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.

Authors:  Paul Lu; Yaozhi Wang; Lori Graham; Karla McHale; Mingyong Gao; Di Wu; John Brock; Armin Blesch; Ephron S Rosenzweig; Leif A Havton; Binhai Zheng; James M Conner; Martin Marsala; Mark H Tuszynski
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

4.  Promotion of survival and differentiation of neural stem cells with fibrin and growth factor cocktails after severe spinal cord injury.

Authors:  Paul Lu; Lori Graham; Yaozhi Wang; Di Wu; Mark Tuszynski
Journal:  J Vis Exp       Date:  2014-07-27       Impact factor: 1.355

Review 5.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

6.  Integration of Transplanted Neural Precursors with the Injured Cervical Spinal Cord.

Authors:  Victoria M Spruance; Lyandysha V Zholudeva; Kristiina M Hormigo; Margo L Randelman; Tatiana Bezdudnaya; Vitaliy Marchenko; Michael A Lane
Journal:  J Neurotrauma       Date:  2018-04-24       Impact factor: 5.269

7.  Rapid induction of functional and morphological continuity between severed ends of mammalian or earthworm myelinated axons.

Authors:  A B Lore; J A Hubbell; D S Bobb; M L Ballinger; K L Loftin; J W Smith; M E Smyers; H D Garcia; G D Bittner
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

8.  Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy.

Authors:  Katja M Piltti; Desirée L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-02-14       Impact factor: 6.940

Review 9.  The curious ability of polyethylene glycol fusion technologies to restore lost behaviors after nerve severance.

Authors:  G D Bittner; D R Sengelaub; R C Trevino; J D Peduzzi; M Mikesh; C L Ghergherehchi; T Schallert; W P Thayer
Journal:  J Neurosci Res       Date:  2015-11-03       Impact factor: 4.164

10.  Choosing the right cell for spinal cord repair.

Authors:  Lyandysha V Zholudeva; Michael A Lane
Journal:  J Neurosci Res       Date:  2018-11-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.